Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    Open Studies | "Histoplasmosis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Treatment for Presumed Ocular Histoplasmosis
Condition: Ocular Histoplasmosis
Intervention: Drug: aflibercept
2 Unknown  Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome
Condition: Ocular Histoplasmosis Syndrome
Intervention: Drug: ranibizumab
3 Unknown  Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis
Condition: Presumed Ocular Histoplasmosis (POHS)
Interventions: Drug: ranibizumab;   Drug: verteporfin
4 Recruiting Prevalence of Histoplasmosis in HIV + Patients With a Rapid Diagnostic Test in West Indies
Condition: HIV
Intervention:

Indicates status has not been verified in more than two years